Ashish Khanna

Discovery and Preclinical Profile of Saxagliptin (BMS-477118):  A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

David J. Augeri, Jeffrey A. Robl, David A. Betebenner et al. · Journal of Medicinal Chemistry · 2005 · 617 citations · Full text

Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study

Tài Pham, Leo Heunks, Giacomo Bellani et al. · The Lancet Respiratory Medicine · 2023 · 243 citations · Full text

Critical Care Medicine, Wean Safe, Intensive Care Units +8

Serratia Marcescens - A Rare Opportunis - tic Nosocomial Pathogen and Measures to Limit its Spread in Hospitalized Patients

Ashish Khanna · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · 2013 · 193 citations · Full text

In Vitro Characterization and Pharmacokinetics of Dapagliflozin (BMS-512148), a Potent Sodium-Glucose Cotransporter Type II Inhibitor, in Animals and Humans

Mary T. Obermeier, Ming Yao, Ashish Khanna et al. · Drug Metabolism and Disposition · 2009 · 176 citations

Synthesis of Novel Potent Dipeptidyl Peptidase IV Inhibitors with Enhanced Chemical Stability:  Interplay between the N-Terminal Amino Acid Alkyl Side Chain and the Cyclopropyl Group of α-Aminoacyl-<scp>l</scp>-<i>cis</i>-4,5-methanoprolinenitrile-Based Inhibitors

David R. Magnin, Jeffrey A. Robl, Richard Sulsky et al. · Journal of Medicinal Chemistry · 2004 · 103 citations · Full text

Glycobiology, Methanoprolinenitrile-containing Dipeptide Mimetics, Pharmacotherapy +19